Books > Social sciences > Sociology, social studies > Social issues
|
Buy Now
Conservatism, Consumer Choice, and the Food and Drug Administration during the Reagan Era - A Prescription for Scandal (Paperback)
Loot Price: R1,238
Discovery Miles 12 380
|
|
Conservatism, Consumer Choice, and the Food and Drug Administration during the Reagan Era - A Prescription for Scandal (Paperback)
Expected to ship within 12 - 17 working days
|
In the last quarter of the 20th century, politicians in Washington,
as well as interest groups, regulatory policy makers, and drug
industry leaders were forced to confront the hot-button issue of
pharmaceutical regulation. The struggle always centered on product
innovation, consumer protection, and choice in the free market. As
the American economy stuttered in the late 1970s, the stakes were
extremely high for the powerful drug industry and the American
public. At the center of this drama was the Food and Drug
Administration, which was censured from both the left and right of
the political spectrum for being too strict and too lenient in the
application of its regulatory powers. Lucas Richert explores the
FDA, drugs, and politics in the context of the watershed Reagan
era, a period when the rhetoric of limited government, reduced
regulation, and enhanced cooperation between businesses and U.S.
regulatory agencies was on the ascent. As he investigates the
controversies surrounding Laetrile, Reye's Syndrome, Oraflex,
patient package inserts, diet pills, and HIV/AIDS drugs, Richert
argues that the practical application of conservative economic
principles to the American drug industry was A Prescription for
Scandal.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.